Ekso Bionics Launches GaitCoach Software for EksoNR | CSIMarket News

Ekso Bionics Launches GaitCoach Software for EksoNR

Published | Modified
CSIMarket Newsroom | CSIMarket.com
Illustrative image

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an established leader in the application and development of exoskeleton technology for healthcare and industrial sectors, has announced an innovative leap in gait therapy with the debut of its revolutionary GaitCoach software. The software is set to significantly enhance EksoNR capabilities, marking an exciting advancement in robotics-assisted rehabilitation.

Situated in San Rafael, California, Ekso Bionics is a pioneering figure in the robotics world. The company’s cutting-edge advancements in exoskeleton technology have generated transformative solutions, changing the landscape of physical rehabilitation and industrial workforces.

The latest addition to their portfolio, GaitCoach, signifies a pivotal shift in assisting patients recovering strength, balance, and mobility following a neurological impairment, stroke, or spinal cord injury. The innovative software seamlessly integrates with EksoNR, a top-tier exoskeleton device used in neuro rehab.

GaitCoach is poised to enable unprecedented interaction between clinicians and patients. The unique software allows precise monitoring of a patient’s gait (the pattern of how a person walks) and provides real-time feedback, aiding both in the implementation and evolution of treatment plans.

The introduction of GaitCoach is perfectly timed, considering the rise in demand for such technology due to an aging global population. There’s an increasing trend for neurological disorders and spinal cord injuries worldwide, which necessitates the need for more innovative rehabilitation solutions.

The software optimizes the patient’s pace, direction, and weight-sharing in real-time during therapy sessions. It equations to a more customized, patient-centric approach to physical therapy and rehabilitation. It not only assists therapists in evaluating a patient’s progress but also empowers patients by fostering independence and confidence.

Though the primary use of GaitCoach is for medical rehabilitation, it holds enormous potential for the industrial sector as well. By analyzing the locomotion patterns of workers, GaitCoach could make invaluable contributions to creating ergonomic work environments that minimize physical stress and occupational hazards.

Ekso Bionics has consistently pushed the boundaries of what is possible within medical technology. The launch of GaitCoach cements their position as an innovation-centric organization, fostering necessity-led developments, that are designed to drastically improve quality of life for patients while fostering advancements within the medical rehabilitation industry.

This launch represents an intersection of technology and healthcare that is progressively relevant in a world that is becoming ever more interconnected and digitally inclined. Ekso Bionics’ commitment to delivering groundbreaking solutions like the GaitCoach sets a higher benchmark for exoskeleton technology, potentially catalyzing future developments within this exciting field of study and application.

s:

Ekso Bionics Breaks New Ground in Gait Therapy With the Launch of GaitCoach Software2. Redefining Rehabilitation: Ekso Bionics Launches Groundbreaking GaitCoach Software3. Ekso Bionics Unveils GaitCoach: Revolutionizing the Future of Neuro Rehab4. The Future of Gait Therapy: Ekso Bionics Introduces Pioneering GaitCoach Software5. Paving the Way for Advanced Rehabilitation: Ekso Bionics’ GaitCoach Takes Center Stage

Source for this article: Based on Ekso Bionics Holdings Inc ’s official statement
For details on how CSIMarket validates financial and corporate news, please review our Editorial Standards & Fact-Checking Policy .
Tags:
#ProductServiceNews, #competitors, #Product/ServicesAnnouncement, #EKSO, #Ekso Bionics Holdings Inc, #Industrial Machinery and Components
Share this article:
Link copied to clipboard.

Comments

Comments are available to active subscribers. Subscribe or Log in.
Get the full CSIMarket dataset: Subscribe API License